English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  50685910    Online Users :  242
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"furuse j"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-10 of 25  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2024-06-17 Plain language summary of the FOENIX-CCA2 study: Futibatinib for people with advanced bile duct cancer Goyal, L; Meric-Bernstam, F; Hollebecque, A; Valle, JW; Morizane, C; Karasic, TB; Abrams, TA; Furuse, J; Kelley, RK; Cassier, PA; Klümpen, HJ; Chang, HM; Chen, LT; Tabernero, J; Oh, D; Mahipal, A; Moehler, M; Komatsu, Y; Ahn, DH; Epstein, RS; Halim, AB; Wacheck, V; He, YH; Liu, M; Benhadji, KA; Bridgewater, JA
國家衛生研究院 2023-01-19 Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma Goyal, L; Meric-Bernstam, F; Hollebecque, A; Valle, JW; Morizane, C; Karasic, TB; Abrams, TA; Furuse, J; Kelley, RK; Cassier, PA; Klümpen, HJ; Chang, HM; Chen, LT; Tabernero, J; Oh, DY; Mahipal, A; Moehler, M; Mitchell, EP; Komatsu, Y; Masuda, K; Ahn, D; Epstein, RS; Halim, AB; Fu, Y; Salimi, T; Wacheck, V; He, Y; Liu, M; Benhadji, KA; Bridgewater, JA
國立成功大學 2023 Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pa Hashimoto, D.;Satoi, Satoi S.;Fujii, T.;Sho, M.;He, J.;Hackert, T.;Del, Chiaro M.;Jang, Jang J.-Y.;Gulla, A.;Yoon, Yoon Y.-S.;Shan, Y.-S.;Lou, W.;Valente, R.;Furuse, J.;Oba, A.;Nagai, M.;Terai, Terai T.;Tanaka, H.;Sakai, A.;Yamamoto, T.;Yamaki, S.;Matsumoto, I.;Murakami, Y.;Takaori, K.;Takeyama, Y.
臺大學術典藏 2022-09-15T01:08:58Z A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies Yamamoto N.; Ryoo B.-Y.; Keam B.; Kudo M.; Chia-Chi Lin; Kunieda F.; Ball H.A.; Moran D.; Komatsu K.; Takeda K.; Fukuda M.; Furuse J.; Morita S.; Doi T.
臺大學術典藏 2022-08-19T00:21:03Z Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion Chen P.-J.; Furuse J.; Han K.-H.; CHIUN HSU; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W.
國家衛生研究院 2022-06 Updated results of the FOENIX-CCA2 trial: Efficacy and safety of futibatinib in intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements Goyal, L;Meric-Bernstam, F;Hollebecque, A;Morizane, C;Valle, JW;Karasic, TB;Abrams, TA;Kelley, RK;Cassier, PA;Furuse, J;Klumpen, HJ;Chang, HM;Chen, LT;Komatsu, Y;Masuda, K;Ahn, DH;Li, K;Benhadji, KA;Wacheck, V;Bridgewater, JA
臺大學術典藏 2021-09-01T01:54:13Z Liver cancer working group report Kudo M.; Han K.H.; Kokudo N.; ANN-LII CHENG; Choi B.I.; Furuse J.; Izumi N.; Park J.-W.; Poon R.T.; Sakamoto M.
臺大學術典藏 2021-09-01T01:53:48Z Randomized phase iii study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: Gest study Ueno H.; Ioka T.; Ikeda M.; Ohkawa S.; Yanagimoto H.; Boku N.; Fukutomi A.; Sugimori K.; Baba H.; Yamao K.; Shimamura T.; Sho M.; Kitano M.; ANN-LII CHENG; Mizumoto K.; Chen J.-S.; Furuse J.; Funakoshi A.; Hatori T.; Yamaguchi T.; Egawa S.; Sato A.; Ohashi Y.; Okusaka T.; Tanaka M.
國家衛生研究院 2021-09 Primary results of phase 2 FOENIX-CCA2: the irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements Mohler, M;Goyal, L;Meric-Bernstam, F;Hollebecque, A;Morizane, C;Valle, JW;Karasic, TB;Abrams, TA;Kelley, RK;Cassier, P;Furuse, J;Klumpen, HJ;Chang, HM;Chen, LT;Komatsu, Y;Masuda, K;Ahn, D;He, Y;Soni, N;Benhadji, KA;Bridgewater, JA
臺大學術典藏 2021-08-31T06:29:37Z Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study Hagiwara Y.; Ohashi Y.; Okusaka T.; Ueno H.; Ioka T.; Boku N.; Egawa S.; Hatori T.; Furuse J.; Mizumoto K.; Ohkawa S.; Yamaguchi T.; Yamao K.; Funakoshi A.; ANN-LII CHENG; Kihara K.; Sato A.; Tanaka M.

Showing items 1-10 of 25  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page